Promaxo Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Promaxo Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10435
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Promaxo Inc (Promaxo) is a medical device company with focus on the development of portable MRI and other technology. The company develops and commercializes office-based, portable magnetic resonance imaging (MRI) devices that possess cellular spatial resolution, besides targeted biopsy and treatment tools, especially for indications in urology. Its product portfolio includes devices for image-guided biopsy and treatment, high resolution and ultra-fast scanning pelvic magnetic resonance (MR) imagers, and automated software for tissue characterization. The company aims at transforming the paradigm of prostate cancer treatment by enabling the patients to be tested, diagnosed and treated by urologists as outpatients. Promaxo is headquartered in Rockville, Maryland, the US.

Promaxo Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Promaxo Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Promaxo Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Promaxo Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Promaxo Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Promaxo Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Promaxo Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 10
Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 11
Promaxo Raises USD0.2 Million in Venture Financing 12
Partnerships 13
MicroPort Scientific to Enter into Distribution Agreement with Promaxo 13
Promaxo Inc – Key Competitors 14
Promaxo Inc – Key Employees 15
Promaxo Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Promaxo Inc, Medical Equipment, Key Facts 2
Promaxo Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Promaxo Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Promaxo Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Promaxo Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Promaxo Inc, Deals By Market, 2012 to YTD 2018 8
Promaxo Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 10
Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 11
Promaxo Raises USD0.2 Million in Venture Financing 12
MicroPort Scientific to Enter into Distribution Agreement with Promaxo 13
Promaxo Inc, Key Competitors 14
Promaxo Inc, Key Employees 15

List of Figures
Promaxo Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Promaxo Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Promaxo Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Promaxo Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Promaxo Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Promaxo Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Promaxo Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Promaxo Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Promaxo Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Shineway Pharmaceutical Group Ltd (2877):企業の財務・戦略的SWOT分析
    Summary China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft ca …
  • bioMerieux SA.:企業のM&A・事業提携・投資動向
    bioMerieux SA. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's bioMerieux SA. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Sumitomo Realty & Development Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Changmao Biochemical Engineering Co., Ltd:企業の戦略・SWOT・財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Canadian Spirit Resources Inc (SPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Spirit Resources Inc (CSRI) is a natural resource provider that provides exploration and development services. The company offers exploration and production of natural gas in Montney Formation of Northeast British Columbia. It provides operation Farrell Creek area which is located a …
  • Group Five Limited (GRF):企業の財務・戦略的SWOT分析
    Group Five Limited (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BB Biotech AG (BION):企業の財務・戦略的SWOT分析
    Summary BB Biotech AG (BB Biotech) is a financial service provider that offers biotechnology investments. The company invests in markets that develop new drugs and therapies for use in the treatment of autoimmune and infectious diseases, oncology disorders, cardiovascular diseases, and metabolic dis …
  • First Electric Cooperative Corporation:企業の戦略的SWOT分析
    First Electric Cooperative Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析
    Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Alon USA Energy Inc (ALJ):企業の財務・戦略的SWOT分析
    Alon USA Energy Inc (ALJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Giant Eagle, Inc.:戦略・SWOT・企業財務分析
    Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report Summary Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kylemore Services Group:企業の戦略・SWOT・財務分析
    Kylemore Services Group - Strategy, SWOT and Corporate Finance Report Summary Kylemore Services Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Transgene SA (TNG):企業の財務・戦略的SWOT分析
    Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targe …
  • Shanghai Institute of Materia Medica Chinese Academy of Sciences:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that provides research and development of traditional Chinese medicine. The institute offers solutions in the areas of drug discovery and drug development. It also offers studies of s …
  • Telecom Argentina S.A.:戦略・SWOT・企業財務分析
    Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Alitair Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alitair Pharmaceuticals Inc (Alitair) is a pharmaceutical company that provides orphan drugs and medicine products. The company provides orphan drug products and RX and OTC cough and cold products. It offers orphan drug products such as ALT and oral drugs that are widely used to treat variou …
  • Blood Cell Storage Inc:医療機器:M&Aディール及び事業提携情報
    Summary Blood Cell Storage Inc (BCSI) is a medical device company that discovers and develops bio-medical technology products. The company’s products comprise IVF safe sens, platelets ph safe, and nucleic acid extraction systems, among others. Its IVF safe sens comprise trackstation and in-vessel mo …
  • China Telecom Corporation Limited:企業の戦略・SWOT・財務分析
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • CEPS A.S.:企業の戦略的SWOT分析
    CEPS A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Ameren Corp (AEE):企業の財務・戦略的SWOT分析
    Ameren Corp (AEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆